Validation of Warfarin Pharmacogenetic Algorithms in Real Clinical Practice

被引：0
|
作者：
Marin-Leblanc, Melina [1 ]
Perreault, Sylvie [1 ]
Dube, Marie-Pierre [2 ]
机构：
[1] Univ Montreal, Pharm, Montreal, PQ, Canada
[2] Montreal Heart Inst, Montreal, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
482
引用
收藏
页码：S204 / S204
页数：1
相关论文
共 50 条
  • [21] Pharmacogenetic Testing for Warfarin Dosing Still Awaits Validation Reply
    Epstein, Robert S.
    Moyer, Thomas P.
    Aubert, Ronald E.
    O'Kane, Dennis J.
    Xia, Fang
    Teagarden, J. Russell
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (06) : 756 - 757
  • [22] Clinical and pharmacogenetic data used to estimate warfarin dosing
    不详
    [J]. PHARMACOGENOMICS, 2009, 10 (04) : 519 - 519
  • [23] Accuracy assessment of pharmacogenetic algorithms for warfarin dose prediction in Chinese patients
    Lei, Xiaoying
    Guo, Yanhai
    Sun, Jianbin
    Zhou, Heping
    Liu, Yonglan
    Liang, Ping
    Yan, Zhen
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (05) : 541 - 544
  • [24] Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort
    Shin, Jaekyu
    Cao, Diana
    [J]. PHARMACOGENOMICS, 2011, 12 (01) : 125 - 134
  • [25] Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
    Liu, Rong
    Li, Xi
    Zhang, Wei
    Zhou, Hong-Hao
    [J]. PLOS ONE, 2015, 10 (08):
  • [26] Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon
    Verhoef, Talitha I.
    Redekop, William K.
    Daly, Ann K.
    van Schie, Rianne M. F.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (04) : 626 - 641
  • [27] Clinical and economic consequences of pharmacogenetic-guided dosing of warfarin
    Verhoef, Talitha I.
    Schalekamp, Tom
    Redekop, William K.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (04) : 375 - 378
  • [28] Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
    Gage, B. F.
    Eby, C.
    Johnson, J. A.
    Deych, E.
    Rieder, M. J.
    Ridker, P. M.
    Milligan, P. E.
    Grice, G.
    Lenzini, P.
    Rettie, A. E.
    Aquilante, C. L.
    Grosso, L.
    Marsh, S.
    Langaee, T.
    Farnett, L. E.
    Voora, D.
    Veenstra, D. L.
    Glynn, R. J.
    Barrett, A.
    McLeod, H. L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 326 - 331
  • [29] Pharmacogenetic dose recommendations in clinical practice
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    [J]. EJHP PRACTICE, 2011, 17 (05): : 28 - 29
  • [30] Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice
    Munoz-Aceituno, E.
    Butron-Bris, B.
    Ovejero-Benito, M. C.
    Sahuquillo-Torralba, A.
    Baniandres Rodriguez, O.
    Herrera-Acosta, E.
    Rivera-Diaz, R.
    Ferran, M.
    Sanchez-Carazo, J. L.
    Riera-Monroig, J.
    Pujol-Montcusi, J.
    Vidal, D.
    de la Cueva, P.
    Garcia-Bustinduy, M.
    Ruiz-Villaverde, R.
    Ballesca, F.
    Llamas-Velasco, M.
    Navares, M.
    Palomar-Moreno, I.
    Sanchez-Garcia, I.
    Garcia-Martinez, J.
    Novalbos, J.
    Zubiaur, P.
    Abad-Santos, F.
    Dauden-Tello, E.
    de la Fuente, H.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (09) : 1783 - 1790
12345